[ad_1]
The "cancer controversy" of high blood pressure has recently been the second incident
Vaccination against rabies of pets (Seoul = Yonhap News) The cat is vaccinated against rabies. 2017.4.10 [email protected] <기사와 관련 없음>
(based in Hong Kong) Ahn Seung-seop correspondent = China is rapidly becoming a 'giant of medicine' based on huge domestic demand, but questioning the credibility of drugs manufactured in China
According to Hong Kong South China Morning Post (SCMP) on the 17th, the Chinese Pharmaceutical Supervision Authority recently announced that "Changchun Biotechnology "in Changchun City, Jilin Province,
discovered that he was manipulating data relating to the manufacture of rabies vaccine" Vero-cell ", one of the main products of the company.
] Changchun ChangSung is the second largest rabies vaccine market in China with a market share of 23%.
Last year, only 354,000 sets of rabies vaccines were produced
The rabies vaccine produced by the company also obtained marketing approval from India, Cambodia, from Nigeria, etc.
Changchun Changsung issued a statement saying: "We voluntarily recovered the rabies vaccine sent to the disease control center and the hospital."
Before this incident, there was had a controversy over the occurrence of hypertension and carcinogenesis in China, which led to the overall reliability of Chinese medicines.
The European Medicines Agency (EMA) filed a lawsuit against the drug valsartan, a Chinese pharmaceutical manufacturer, Nitrosodimethylamine (NDMA), a potentially dangerous substance, was released on May 5.
28 countries, including Korea, announced that they would stop selling this product,
In 2016, it was discovered that China had sold vaccines worth more than $ 85 million dollars (about 96 billion won) that have pbaded the validity period or have been stored for many years, causing the overthrow of China. Changchun Changsung, a member of the rabies vaccine incident, suffered from the discovery that the DTC vaccine produced by the company failed to meet quality standards last year. "This incident is a serious blow to the reliability of Chinese medicines," said Taorina, a vaccine expert at the Shanghai Centers for Disease Control and Prevention. "
I should cancel the license for the production of ChangSung's medicine and make a huge fine."
[ad_2]
Source link
